Literature DB >> 15653490

Microbiology. TB--a new target, a new drug.

Stewart T Cole1, Pedro M Alzari.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653490     DOI: 10.1126/science.1108379

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  17 in total

1.  Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Authors:  S Cumero; F Fogolari; R Domenis; R Zucchi; I Mavelli; S Contessi
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

2.  Dietary bioflavonoids inhibit Escherichia coli ATP synthase in a differential manner.

Authors:  Nagababu Chinnam; Prasanna K Dadi; Shahbaaz A Sabri; Mubeen Ahmad; M Anaul Kabir; Zulfiqar Ahmad
Journal:  Int J Biol Macromol       Date:  2010-03-25       Impact factor: 6.953

Review 3.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

4.  Effect of structural modulation of polyphenolic compounds on the inhibition of Escherichia coli ATP synthase.

Authors:  Zulfiqar Ahmad; Mubeen Ahmad; Florence Okafor; Jeanette Jones; Abdelmajeed Abunameh; Rakesh P Cheniya; Ismail O Kady
Journal:  Int J Biol Macromol       Date:  2012-01-20       Impact factor: 6.953

5.  Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis.

Authors:  Joy Debnath; Shajila Siricilla; Bajoie Wan; Dean C Crick; Anne J Lenaerts; Scott G Franzblau; Michio Kurosu
Journal:  J Med Chem       Date:  2012-04-06       Impact factor: 7.446

Review 6.  ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptides.

Authors:  Zulfiqar Ahmad; Florence Okafor; Sofiya Azim; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

7.  Improved synthesis of capuramycin and its analogues.

Authors:  Yong Wang; Shajila Siricilla; Bilal A Aleiwi; Michio Kurosu
Journal:  Chemistry       Date:  2013-09-06       Impact factor: 5.236

8.  Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection.

Authors:  J W C Alffenaar; W A Nienhuis; F de Velde; A T Zuur; A M A Wessels; D Almeida; J Grosset; O Adjei; D R A Uges; T S van der Werf
Journal:  Antimicrob Agents Chemother       Date:  2010-06-28       Impact factor: 5.191

9.  Concise synthesis of capuramycin.

Authors:  Michio Kurosu; Kai Li; Dean C Crick
Journal:  Org Lett       Date:  2009-06-04       Impact factor: 6.005

10.  Bedaquiline metabolism: enzymes and novel metabolites.

Authors:  Ke Liu; Feng Li; Jie Lu; Shinlan Liu; Kenneth Dorko; Wen Xie; Xiaochao Ma
Journal:  Drug Metab Dispos       Date:  2014-02-10       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.